Current perspectives on established and novel therapies for pathological neovascularization in retinal disease
Authors:
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 164, 321-325
Abstract
No abstract availableKeywords
Funding Information
- Irish Research Council
- National Children's Research Centre
- Health Research Board
- BrightFocus Foundation
- Science Foundation Ireland
This publication has 23 references indexed in Scilit:
- Seven-Year Outcomes in Ranibizumab-Treated Patients in ANCHOR, MARINA, and HORIZONOphthalmology, 2013
- The worldwide epidemic of diabetic retinopathyIndian Journal Of Ophthalmology, 2012
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studiesThe Lancet, 2010
- Age-Related Macular DegenerationNew England Journal of Medicine, 2008
- Pathophysiological consequences of VEGF-induced vascular permeabilityNature, 2005
- Mini‐review: Transendothelial migration of leukocytes: through the front door or around the side of the house?European Journal of Immunology, 2004
- Role of tissue factor in embryonic blood vessel developmentNature, 1996
- Heterozygous embryonic lethality induced by targeted inactivation of the VEGF geneNature, 1996
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971